{"id":"https://openalex.org/W7124459840","doi":"https://doi.org/10.1111/cts.70447","title":"Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science","display_name":"Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7124459840","doi":"https://doi.org/10.1111/cts.70447","pmid":"https://pubmed.ncbi.nlm.nih.gov/41540835","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12809047"},"language":"en","primary_location":{"id":"doi:10.1111/cts.70447","doi":"https://doi.org/10.1111/cts.70447","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70447","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1111/cts.70447","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006053055","display_name":"Rajeev M. Menon","orcid":"https://orcid.org/0000-0002-2945-0449","observed_orcids":["https://orcid.org/0000-0002-2945-0449"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rajeev Menon","raw_affiliation_strings":["Clinical Pharmacology AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0000-0002-2945-0449","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049228395","display_name":"Emarjola Bako","orcid":"https://orcid.org/0009-0002-1239-170X","observed_orcids":["https://orcid.org/0009-0002-1239-170X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emarjola Bako","raw_affiliation_strings":["Pharmacovigilance and Patient Safety AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0009-0002-1239-170X","affiliations":[{"raw_affiliation_string":"Pharmacovigilance and Patient Safety AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087605474","display_name":"S. Liu","orcid":"https://orcid.org/0000-0002-6627-4843","observed_orcids":["https://orcid.org/0000-0002-6627-4843"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuhan Liu","raw_affiliation_strings":["Clinical Pharmacology AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0000-0002-6627-4843","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111592710","display_name":"James Joseph Stec","orcid":"https://orcid.org/0000-0003-2387-3720","observed_orcids":["https://orcid.org/0000-0003-2387-3720"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Stec","raw_affiliation_strings":["Medical Affairs AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0000-0003-2387-3720","affiliations":[{"raw_affiliation_string":"Medical Affairs AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123252082","display_name":"Sheetal Thakur","orcid":"https://orcid.org/0009-0003-7063-3911","observed_orcids":["https://orcid.org/0009-0003-7063-3911"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheetal Thakur","raw_affiliation_strings":["Regulatory Affairs Oncology AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0009-0003-7063-3911","affiliations":[{"raw_affiliation_string":"Regulatory Affairs Oncology AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078059849","display_name":"Emily Deutschman","orcid":"https://orcid.org/0000-0002-2980-2299","observed_orcids":["https://orcid.org/0000-0002-2980-2299"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Deutschman","raw_affiliation_strings":["Precision Medicine Oncology AbbVie Inc.  Waltham Massachusetts USA"],"raw_orcid":"https://orcid.org/0000-0002-2980-2299","affiliations":[{"raw_affiliation_string":"Precision Medicine Oncology AbbVie Inc.  Waltham Massachusetts USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027000971","display_name":"Olga Ab","orcid":"https://orcid.org/0000-0003-0188-3231","observed_orcids":["https://orcid.org/0000-0003-0188-3231"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Ab","raw_affiliation_strings":["Precision Medicine Oncology AbbVie Inc.  Waltham Massachusetts USA"],"raw_orcid":"https://orcid.org/0000-0003-0188-3231","affiliations":[{"raw_affiliation_string":"Precision Medicine Oncology AbbVie Inc.  Waltham Massachusetts USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5123223618","display_name":"Shweta Jain","orcid":"https://orcid.org/0009-0000-7923-0180","observed_orcids":["https://orcid.org/0009-0000-7923-0180"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shweta Jain","raw_affiliation_strings":["Clinical Development Oncology AbbVie Inc.  North Chicago Illinois USA"],"raw_orcid":"https://orcid.org/0009-0000-7923-0180","affiliations":[{"raw_affiliation_string":"Clinical Development Oncology AbbVie Inc.  North Chicago Illinois USA","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006053055"],"corresponding_institution_ids":["https://openalex.org/I2948539688"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":7.1213,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.97545079,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"19","issue":"1","first_page":"e70447","last_page":"e70447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirvetuximab-soravtansine","display_name":"mirvetuximab soravtansine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9039999842643738},{"id":"https://openalex.org/keywords/folate-receptor-alpha","display_name":"folate receptor alpha","score":0.9549999833106995},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.859000027179718},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/microtubule-dynamic-instability","display_name":"microtubule dynamic instability","score":0.8539999723434448},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5864999890327454},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.527899980545044},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5181999802589417},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.517799973487854},{"id":"https://openalex.org/C2992773878","wikidata":"https://www.wikidata.org/wiki/Q7645976","display_name":"Epithelial ovarian cancer","level":4,"score":0.4352000057697296},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41600000858306885},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41370001435279846},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.4083000123500824},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.40220001339912415},{"id":"https://openalex.org/C2775883341","wikidata":"https://www.wikidata.org/wiki/Q1233836","display_name":"Fallopian tube","level":2,"score":0.4018000066280365},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.373199999332428},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3675999939441681},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.365200012922287},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.3465999960899353},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.34540000557899475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34060001373291016},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.33230000734329224},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32120001316070557},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.31929999589920044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3102000057697296},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.30720001459121704},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3021000027656555},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.29280000925064087},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2892000079154968},{"id":"https://openalex.org/C96526673","wikidata":"https://www.wikidata.org/wiki/Q4867047","display_name":"Basic science","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2827000021934509},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.27320000529289246},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.26809999346733093},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.26510000228881836},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.2515000104904175}],"mesh":[{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D057170","descriptor_name":"Translational Research, Biomedical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058975","descriptor_name":"Folate Receptor 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D058975","descriptor_name":"Folate Receptor 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/cts.70447","doi":"https://doi.org/10.1111/cts.70447","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70447","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12809047","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12809047/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12809047/pdf/CTS-19-e70447.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Sci","raw_type":"Text"},{"id":"pmid:41540835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41540835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and translational science","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2445d0acbfb44475873e2610124490a7","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/2445d0acbfb44475873e2610124490a7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Translational Science, Vol 19, Iss 1, Pp n/a-n/a (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/cts.70447","doi":"https://doi.org/10.1111/cts.70447","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70447","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7124459840.pdf","grobid_xml":"https://content.openalex.org/works/W7124459840.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1963776452","https://openalex.org/W1971738718","https://openalex.org/W1996737831","https://openalex.org/W2024132257","https://openalex.org/W2053558130","https://openalex.org/W2097529056","https://openalex.org/W2108849103","https://openalex.org/W2179105349","https://openalex.org/W2567395185","https://openalex.org/W2608845032","https://openalex.org/W2789756749","https://openalex.org/W2887481574","https://openalex.org/W3011085857","https://openalex.org/W3099043519","https://openalex.org/W3135098376","https://openalex.org/W3195575266","https://openalex.org/W4235223714","https://openalex.org/W4311484871","https://openalex.org/W4318580181","https://openalex.org/W4319216343","https://openalex.org/W4377220075","https://openalex.org/W4386030180","https://openalex.org/W4387866971","https://openalex.org/W4389376362","https://openalex.org/W4391123251","https://openalex.org/W4392482408","https://openalex.org/W4393988890","https://openalex.org/W4399517427","https://openalex.org/W4400075828","https://openalex.org/W4401179059","https://openalex.org/W4402720041","https://openalex.org/W4403789396","https://openalex.org/W4404112304","https://openalex.org/W4404850983","https://openalex.org/W4409097319","https://openalex.org/W4411643039"],"related_works":["https://openalex.org/W2978001861","https://openalex.org/W4389791279","https://openalex.org/W4385719183","https://openalex.org/W4295226778","https://openalex.org/W2898602366","https://openalex.org/W4405837728","https://openalex.org/W7164680684","https://openalex.org/W4312139653","https://openalex.org/W3089048329","https://openalex.org/W7125935417"],"abstract_inverted_index":{"Mirvetuximab":[0],"soravtansine":[1],"(MIRV)":[2],"is":[3],"an":[4,129,183,201],"antibody-drug":[5],"conjugate":[6],"(ADC)":[7],"composed":[8],"of":[9,69,103,112,132,138,164,187,195,204,215],"the":[10,22,38,110,136],"DM4":[11,39,48],"payload":[12,40],"conjugated":[13],"to":[14,30,77,101,107,142],"a":[15,83,125,191],"folate":[16],"receptor":[17],"\u03b1":[18],"(FR\u03b1)-targeting":[19],"antibody":[20],"via":[21],"cleavable":[23],"sulfo-SPDB":[24],"linker.":[25],"MIRV":[26,143,156,165,213],"targets":[27],"and":[28,35,46,49,62,74,95,116,140,200,219,223],"binds":[29],"FR\u03b1":[31],"with":[32,128,176],"high":[33,177],"affinity":[34],"specificity,":[36],"releasing":[37],"intracellularly":[41],"following":[42],"MIRV-FR\u03b1":[43],"complex":[44],"internalization":[45],"degradation.":[47],"its":[50,75],"metabolite":[51],"S-methyl-DM4":[52],"suppress":[53],"microtubule":[54],"dynamic":[55],"instability,":[56],"which":[57],"triggers":[58],"cell":[59],"cycle":[60],"arrest":[61],"apoptosis.":[63],"Selective":[64],"FR\u03b1-overexpression":[65],"in":[66,145,150,174],"\u2265":[67],"90%":[68],"epithelial":[70,89],"ovarian":[71,90,121],"tumor":[72],"cells":[73],"ability":[76],"internalize":[78],"large":[79],"molecules":[80],"make":[81],"it":[82],"highly":[84],"attractive":[85],"ADC":[86],"target":[87],"for":[88,153],"cancers":[91],"(including":[92],"primary":[93],"peritoneal":[94],"fallopian":[96],"tube":[97],"cancers).":[98],"Although":[99],"up":[100],"80%":[102],"patients":[104,175],"initially":[105],"respond":[106],"platinum-based":[108],"therapies,":[109],"majority":[111],"tumors":[113],"will":[114],"recur":[115],"become":[117],"platinum-resistant.":[118],"Unfortunately,":[119],"platinum-resistant":[120],"cancer":[122],"(PROC)":[123],"carries":[124],"poor":[126],"prognosis":[127],"overall":[130,202],"survival":[131,194,203],"12-14":[133],"months":[134],"from":[135],"time":[137],"platinum-resistance,":[139],"prior":[141],"approval":[144],"2022,":[146],"little":[147],"had":[148],"changed":[149],"treatment":[151],"options":[152],"decades.":[154],"The":[155],"Phase":[157],"3":[158],"registrational":[159],"trial":[160],"(MIRASOL)":[161],"showed":[162],"superiority":[163],"vs.":[166],"chemotherapy":[167],"(paclitaxel,":[168],"pegylated":[169],"liposomal":[170],"doxorubicin,":[171],"or":[172],"topotecan)":[173],"(\u2265":[178],"75%)":[179],"FR\u03b1-expression":[180],"PROC,":[181],"showing":[182],"objective":[184],"response":[185],"rate":[186],"42%":[188],"versus":[189,197,206],"16%,":[190],"median":[192],"progression-free":[193],"5.6":[196],"4.0":[198],"months,":[199],"16.5":[205],"12.8":[207],"months.":[208],"Here,":[209],"we":[210],"briefly":[211],"review":[212],"mechanism":[214],"action,":[216],"pharmacokinetics,":[217],"pharmacodynamics,":[218],"key":[220],"clinical":[221],"efficacy":[222],"safety":[224],"data.":[225]},"counts_by_year":[{"year":2026,"cited_by_count":9}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-01-17T00:00:00"}